FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials.
Dominic Kaddu-MulindwaBettina AltmannGerhard HeldStephanie AngelStephan StilgenbauerLorenz ThurnerMoritz BewarderMaren SchwierMichael PfreundschuhMarkus LöfflerKarin MenhartJirka GrosseMarita ZiepertKen HerrmannUlrich DührsenAndreas HüttmannFrancesco BarbatoViola PoeschelDirk HellwigPublished in: European journal of nuclear medicine and molecular imaging (2021)
NCT00554164 and NCT01478542.